Skip to content

The clinical trial of WEFRE Rehab System for patients with impairment upper limb caused by brain and neurological diseases

The clinical trial of WEFRE Rehab System for patients with impairment upper limb caused by brain and neurological diseases

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
TCTR
Registry ID
TCTR20190221005
Enrollment
10
Registered
2019-02-21
Start date
2019-03-18
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Impairment upper limb caused by brain and neurological diseases

Interventions

Conventional occupational therapy for 30 minutes and WEFRE training for 30 minutes a day&#44
Experimental Device
WEFRE Group

Sponsors

CPMO/NSTDA Thailand
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Good consciousness. Constant/normal vital sign. Nerve System has been in good condition at least 48 hrs. Can sit continuously at least 30 minutes. Has not participated in any research that related to upper extremity. Subject commits to participate in the trial.

Exclusion criteria

Exclusion criteria: Not the first time of stroke. Arm pain condition, spastic at elbow and hand. Modified Ashworth Scale is more than 2. Severe aphasia. Thai Mental State Examination score is less than 24. Mild to severe depression condition based on Thai Geriatric Depression Scale (TGDS).

Design outcomes

Primary

MeasureTime frame
Motor Power 4th week Medical research council,Fugl-Meyer Assessment- upper extremity section 4th week Point,Spasticity using Modified Ashworth scale 4th week Point,Barthel ADL Index 4th week Point

Secondary

MeasureTime frame
Satisfactory of the system 4th week Level

Countries

Thailand

Contacts

Public ContactWinai Chonnaparamutt

NECTEC

winai.chonnaparamutt@nectec.or.th02 564 6900

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Apr 4, 2026